Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Sniderman

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Clinical Chemistry|August 1, 1997
Counterpoint: to (measure apo) B or not to (measure apo) B: a critique of modern medical decision-makingA D Sniderman
European Journal of Clinical Investigation|December 15, 2000
Postprandial hypertriglyceridemia(s): time to enlarge our pathophysiologic perspectiveA D Sniderman
Obesity Research|October 6, 1999
Acylation stimulating protein: myth, magic, or major metabolic playerA D Sniderman
The Canadian Journal of Cardiology|March 1, 1992
The measurement of apolipoprotein B should replace the conventional lipid profile in screening for cardiovascular riskA D Sniderman
The Canadian Journal of Cardiology|March 1, 1992
The Academic Medicine-Health Care Industry complex: is there one, and if so, should we care?A D Sniderman
The Canadian Journal of Cardiology|October 1, 1996
The clinical case report: a tool for hypothesis generationA D Sniderman
Lancet (London, England)|February 16, 2000
Lowering of LDL cholesterolA D Sniderman
Lancet (London, England)|May 18, 1996
The governance of clinical trialsA D Sniderman
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 8, 2003
Through a glass darkly: complex modulation of common metabolic faultsA D Sniderman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 16, 2000
The need for greater involvement of regulatory agencies in assessing adverse drug reactionsA D Sniderman
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Clinical Chemistry|August 1, 1997
Counterpoint: to (measure apo) B or not to (measure apo) B: a critique of modern medical decision-makingA D Sniderman
European Journal of Clinical Investigation|December 15, 2000
Postprandial hypertriglyceridemia(s): time to enlarge our pathophysiologic perspectiveA D Sniderman
Obesity Research|October 6, 1999
Acylation stimulating protein: myth, magic, or major metabolic playerA D Sniderman
The Canadian Journal of Cardiology|March 1, 1992
The measurement of apolipoprotein B should replace the conventional lipid profile in screening for cardiovascular riskA D Sniderman
The Canadian Journal of Cardiology|March 1, 1992
The Academic Medicine-Health Care Industry complex: is there one, and if so, should we care?A D Sniderman
The Canadian Journal of Cardiology|October 1, 1996
The clinical case report: a tool for hypothesis generationA D Sniderman
Lancet (London, England)|February 16, 2000
Lowering of LDL cholesterolA D Sniderman
Lancet (London, England)|May 18, 1996
The governance of clinical trialsA D Sniderman
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 8, 2003
Through a glass darkly: complex modulation of common metabolic faultsA D Sniderman
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 16, 2000
The need for greater involvement of regulatory agencies in assessing adverse drug reactionsA D Sniderman
Pageof 14